Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.5 USD | +6.69% | -14.84% | +9.00% |
06-18 | Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Ahead of Speeches by Fed Officials | MT |
06-14 | Oppenheimer Adjusts UroGen Pharma Price Target to $40 From $32, Maintains Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.00% | 559M | |
+15.50% | 122B | |
+20.48% | 113B | |
+8.24% | 22.84B | |
-20.40% | 20.72B | |
-16.19% | 16.51B | |
-13.63% | 16.39B | |
-44.35% | 15.83B | |
+2.32% | 13.49B | |
+66.92% | 11.67B |
- Stock Market
- Equities
- URGN Stock
- News UroGen Pharma Ltd.
- HC Wainwright Adjusts Price Target on UroGen Pharma to $60 From $54, Maintains Buy Rating